• UK Government provides more clarity on the scope of the National Security and Investment Bill (“NSIB”)
    Read more
  • Impact of Covid-19 on market abuse risks on businesses in the life sciences sector
    Read more
  • COVID-19 considerations for life sciences M&A
    Read more

Life sciences

Straightforward, business-friendly advice from lawyers who understand the unique challenges and opportunities presented by the life sciences sector.  We enjoy spending time getting to know our clients and working alongside them for the long term.

Register here to receive updates from the Stephenson Harwood life sciences group.

We work with a wide range of clients from the life sciences sector including:

  • pharmaceutical companies
  • biotechnology companies
  • medical device and diagnostic companies
  • manufacturers, distributors and logistics companies
  • investors
  • banks and financial institutions
  • brokers and NOMADS